(19)
(11) EP 1 789 067 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.08.2012 Bulletin 2012/33

(45) Mention of the grant of the patent:
23.05.2012 Bulletin 2012/21

(21) Application number: 05786631.1

(22) Date of filing: 12.08.2005
(51) International Patent Classification (IPC): 
A61K 38/05(2006.01)
A61P 1/00(2006.01)
 A61K 38/06(2006.01)
(86) International application number:
PCT/US2005/028851
(87) International publication number:
WO 2006/020930 (23.02.2006 Gazette 2006/08)

(54)

Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system

Verwendung von Wachstumshormon-sekretagoga zur Stimulierung der Motilität des gastrointestinalen Systems

Utilisation de secretagogues d'hormones de croissance pour la stimulation de la motilite du systeme gastro-intestinal

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 12.08.2004 US 600959 P

(43) Date of publication of application:
30.05.2007 Bulletin 2007/22

(73) Proprietor: Helsinn Healthcare S.A.
6912 Lugano / Pazzallo (CH)

(72) Inventor:
  • POLVINO, Wiliam, J.
    Tinton Falls, NJ 07724 (US)

(74) Representative: Zardi, Marco et al
M. Zardi & Co. S.A. Via Pioda 6
6900 Lugano
6900 Lugano (CH)


(56) References cited: : 
EP-A1- 0 657 428
WO-A1-00/01726
US-B1- 6 919 315
 EP-A2- 1 159 964
WO-A1-01/34593
   
  • WINTER DE B Y ET AL: "EFFECT OF GHRELIN AND GROWTH HORMONE-RELEASING PEPTIDE 6 ON SEPTIC ILEUS IN MICE" NEUROGASTROENTEROLOGY AND MOTILITY, BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, GB LNKD- DOI:10.1111/J.1365-2982.2004.00564.X, vol. 16, no. 4, 1 August 2004 (2004-08-01) , pages 439-446, XP009053072 ISSN: 1350-1925
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).